Chemical industry in Argentina

Projects in Argentina

chemXplore tracks 7 projects in Argentina, of which 4 are active.

1 Announced / Concept 1 FEED / Pre-FID 1 FID / Sanctioned 1 Under Construction

4 new construction.

Expected to start operating
2026
none
2027
none
2028
none
2029
none
2030
1 project
2031
1 project

1 of the active projects carry no start-up date yet.

What moved recently
  • 11 September 2026 Aptar Pharma APF Production Line Expansion Berazategui · Operational / Completed
  • 2 September 2026 YPF Industrial Complex Prime-D Diesel Hydrotreater · Announced / Concept
  • 25 August 2026 Raízen Dock Sud Prime-G+ FCC Gasoline Desulfurization Unit · Operational / Completed
  • July 2026 Pampa Energía Bahía Blanca Urea Complex · FID / Sanctioned
  • February 2026 YPF Eni XRG Argentina LNG Vaca Muerta FLNG Development · FEED / Pre-FID

Owners and developers: YPF Sociedad Anónima (2), Eni S.p.A. (1), Fértil Pampa S.A.U. (1), POSCO (1), Pampa Energia S.A. (1), XRG P.J.S.C. (1)

Investors: Banco Santander, S.A. (1), Eni S.p.A. (1), Export-Import Bank of the United States (1), IDB Invest (1), JP Morgan Chase & Co. (1), XRG P.J.S.C. (1)

Contractors, licensors, and offtakers are recorded on all 4 of them For subscribers

Targeting: Natural gas (2), Ammonia (1), Butane (1), Diesel, fuels (1), Ethane (1), Lithium Carbonate (1)

Follow these projects in chemXplore →

Latest Argentinean chemical industry news

2 October 2026
Eni and Argentina discuss Argentina LNG FLNG development

Meeting covered cooperation on gas development via floating liquefaction; Argentina LNG targets 12 MTPA initially, investment decision due end of year and start-up planned for 2030.

1 October 2026
XRG backs Argentina's push to become global LNG supplier

Argentina targets global LNG supply; first phase 12 Mtpa from Vaca Muerta with YPF and Eni partnership, promising over 40,000 jobs and export revenues.

30 September 2026
Lilly’s Foundayo shows cardiovascular safety and durable A1C and weight benefits in ACHIEVE‑4

Once‑daily oral GLP‑1 cut MACE vs insulin glargine, lowered A1C by 1.6% at 52 weeks and produced mean weight loss of 8.1 kg with durable effects to 104 weeks.

30 September 2026
Lilly's EloraTZP (eloralintide + tirzepatide) outperforms tirzepatide 15 mg in Phase 2b obesity and T2D trial

Combination achieved up to 23.3% weight loss (54.1 lbs) and 2.9% A1C reduction versus 14.8% (34.4 lbs) and 2.4% with tirzepatide; Phase 3 to start Q4 2026.

29 September 2026
Lilly: Zepbound (tirzepatide 10 mg, 15 mg) associated with greater weight loss than Wegovy HD (semaglutide 7.2 mg)

An indirect, covariate‑adjusted comparison of SURMOUNT‑1 and STEP UP data shows larger mean and categorical weight‑loss benefits with tirzepatide 10 mg and 15 mg at 72 weeks.

24 September 2026
Lilly's Onswik approved by FDA as once‑weekly basal insulin for adults with type 2 diabetes

FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.

11 September 2026
Aptar Pharma expands APF preservative-free pump production in Argentina

APF multidose preservative‑free pump line commissioned to serve Latin American markets, cutting lead times and improving local supply agility.

2 September 2026
POSCO Holdings secures US$700 million IDB Invest facility for Argentine lithium operations

US$700m short-term facility to finance working capital for two brine lithium plants; preferential tax treatment will lower borrowing costs and improve project competitiveness.

2 September 2026
Axens to deliver modular 5,000 m3/day Prime-D diesel hydrotreater to YPF

Prefabricated modular Prime-D unit trims delivery by six months, reduces CAPEX and limits on-site work while enabling ultra-low sulphur diesel production.

25 August 2026
Equinor reshapes international portfolio — targets 950,000 boepd outside Norway by 2030

Portfolio concentrated into fewer countries, expected ~USD 20bn free cash flow 2026–2030; US, Brazil and Angola to drive growth; higher margins from high-grading and stepped-up exploration.